NASDAQ · ABTC

American Bitcoin Corp.

$5.87 +$0.15 (+2.62%) 1D Pre-market

Key Metrics

$417.56M
Market cap
P/E · TTM
$245.72M
Revenue · TTM
−$228.68M
Net income
EPS · TTM $-0.26
Dividend yield
Free cash flow
Beta · 1Y 3.15
EBITDA · TTM −$256.93M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 13
    From its Jan 30 high, the share price fell 77%.

    Peak close $22.65 on Jan 30; trough close $5.29 on Jul 13. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -77%
  • Jul 7
    The stock moved -23.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 7
  • Mar 31
    The stock moved +17.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 31

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$417.56M
Enterprise value
Shares outstanding73.0M
52-wk range$1.56 – $31.50
Avg volume · 20D3.8M
Net cash
Book value / share$0.78
IndustryFinance Services
ExchangeNASDAQ
About American Bitcoin Corp.
IPO dateSep 3, 2025
Employees2

American Bitcoin Corp is a Bitcoin accumulation platform that integrates scaled Bitcoin mining operations with disciplined accumulation strategies.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S1.70
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating -138.7%
Net -93.1%
FCF
ROE / ROIC -66.5% · —

Financial Health

Current ratio0.13
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital−$97.01M

Cash Flow · TTM

Operating CF −$118.90M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

-0.5
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings